SNTI
Senti Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.21
−2.37%Margins
Gross margin
-2736.4%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
1457.3%
Return on equity
-149.7%
Return on assets
-335.9%
Return on invested capital
0.00x
Asset turnover
-$38.1M
Cash from operations
$0.21
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026